At the International Conference ‘Unified Scientific Approaches towards Regenerative Orthopaedics and Dentistry’ in Venice, Italy, Dr. Lacza has announced the preliminary results of the first double-blind, controlled human study on BoneAlbumin. In a sports surgery indication of BTB harvest site filling, BoneAlbumin resulted in stronger bone stock and significantly reduced donor site pain than either autograft or blood clot filling controls.
